Curative effect of α-lipoic acid on peripheral neuropathy in type 2 diabetes: A clinical study

National Medical Journal of China

Volumn 87, Issue 38, 2007, Pages 2706-2709

  Liu, Fang ^a   Zhang, Yang ^a   Yang, Ming ^a   Liu, Bo ^a   Shen, Ying Di ^a   Jia, Wei Ping ^a   Xiang, Kun San ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Diabetes; Peripheral nervous system diseases; Thioctic acid

Indexed keywords

C REACTIVE PROTEIN; GLUCOSE; HEMOGLOBIN A1C; INSULIN; THIOCTIC ACID;

ADULT; AGED; ARTICLE; BURNING SENSATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETIC NEUROPATHY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROLOGIC EXAMINATION; NON INSULIN DEPENDENT DIABETES MELLITUS; PARESTHESIA; PERIPHERAL NEUROPATHY; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; THORAX PAIN;

AGED; ANTIOXIDANTS; BLOOD GLUCOSE; C-REACTIVE PROTEIN; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; DRUG ADMINISTRATION SCHEDULE; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INFUSIONS, INTRAVENOUS; INSULIN; MALE; MIDDLE AGED; PERIPHERAL NERVOUS SYSTEM DISEASES; THIOCTIC ACID; TREATMENT OUTCOME;

EID: 38549162082     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Sytze van Dam P. Oxidative stress and diabetic neuropathy: pathophysiological mechanisms and treatment perspectives. Diabetes Metab Res Rev,2002,18:176-184.
2. Cowell RM, Russell JW. Nitrosative injury and antioxidant therapy in the management of diabetic neuropathy. J Investig Med,2004, 52:33-44.
3. Bregovskii VB, Posokhina OV, Kaspova IA. Predictors of alpha-lipoic acid treatment efficacy in diabetic polyneuropathy of the lower limbs. Ter Arkh,2005,77:15-19.
4. Ametov AS, Barinov A, Dyck PJ, et al. The sensory symptoms of diabetic polyneuropathy are improved with alpha-lipoic acid: the SYDNEY trial. Diabetes Care,2003,26:770-776.
5. Young MJ, Boulton AJ, MacLeod AF, et al. A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population. Diabetologia, 1993,36:150-154.
6. Bilska A, Wlodek L. Biologic properties of lipoic acid. Postepy Hig Med Dosw, 2002,56:201-219.
7. Chinese source.
8. Moghtaderi A, Bakhshipour A, Rashidi H. Validation of Michigan neuropathy screening instrument for diabetic peripheral neuropathy. Clin Neurol Neurosurg,2006,108:477-481.
9. Ziegler D. Thioctic acid for patients with symptomatic diabetic polyneuropathy: a critical review. Treat Endocrinol, 2004,3:173-189.
10. Hahm JR, Kim BJ, Kim KW. Clinical experience with thioctacid (thioctic acid) in the treatment of distal symmetric polyneuropathy in Korean diabetic patients. J Diabetes Complications,2004,18: 79-85.
11. Ziegler D, Nowak H, Kempler P, et al. Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a meta-analysis. Diabet Med,2004,21:114-121.
12. Stevens MJ, Obrosova I, Cao X, et al. Effects of DL-alpha-lipoic acid on peripheral nerve conduction, blood flow, energy metabolism, and oxidative stress in experimental diabetic neuropathy. Diabetes,2000,49:1006-1115.
13. Haak E, Usadel KH, Kusterer K, et al. Effects of alpha-lipoic acid on microcirculation in patients with peripheral diabetic neuropathy. Exp Clin Endocrinol Diabetes,2000, 108: 168-174.